Evidence map›Paper›PMID 29992973›Full record

ArticleScientific reports2018

A Requirement for Zic2 in the Regulation of Nodal Expression Underlies the Establishment of Left-Sided Identity.

Iain M Dykes, Dorota Szumska, Linta Kuncheria, Rathi Puliyadi, Chiann-Mun Chen, Costis Papanayotou, Helen Lockstone, Christèle Dubourg, Véronique David, Jurgen E Schneider and 7 more

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.5field-weighted citation impact, top 37% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 9 citations in OpenAlex.

  1. Differences in the EarlyJournal of cardiovascular development and disease · 2025
    Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 7 institutions in 3 countries.

Iain M DykesDepartment of Cardiovascular Medicine, BHF Centre of Research Excellence, University of Oxford, Roosevelt Drive, Headington, Oxford, OX3 7BN, United Kingdom. I.M.Dykes@ljmu.ac.uk.
Dorota SzumskaDepartment of Cardiovascular Medicine, BHF Centre of Research Excellence, University of Oxford, Roosevelt Drive, Headington, Oxford, OX3 7BN, United Kingdom.
Linta KuncheriaDepartment of Cardiovascular Medicine, BHF Centre of Research Excellence, University of Oxford, Roosevelt Drive, Headington, Oxford, OX3 7BN, United Kingdom.
Rathi PuliyadiDepartment of Cardiovascular Medicine, BHF Centre of Research Excellence, University of Oxford, Roosevelt Drive, Headington, Oxford, OX3 7BN, United Kingdom.
Chiann-Mun ChenDepartment of Cardiovascular Medicine, BHF Centre of Research Excellence, University of Oxford, Roosevelt Drive, Headington, Oxford, OX3 7BN, United Kingdom.ORCID 0000-0002-7007-3649
Costis PapanayotouInstitut Jacques Monod, UMR 7592, CNRS, Université Paris-Diderot, Sorbonne Paris Cité, 75013, Paris, France.
Helen LockstoneWellcome Trust Centre for Human Genetics, University of Oxford, Roosevelt Drive, Headington, Oxford, OX3 7BN, United Kingdom.
Christèle DubourgFaculté de Médecine, Institut de Génétique et Développement de Rennes, UMR 6290, Université de Rennes 1, Rennes, France.
Véronique DavidFaculté de Médecine, Institut de Génétique et Développement de Rennes, UMR 6290, Université de Rennes 1, Rennes, France.
Jurgen E SchneiderDepartment of Cardiovascular Medicine, BHF Centre of Research Excellence, University of Oxford, Roosevelt Drive, Headington, Oxford, OX3 7BN, United Kingdom.ORCID 0000-0003-0999-5684
Thomas M KeaneWellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridge, CB10 1SA, United Kingdom.ORCID 0000-0001-7532-6898
David J AdamsWellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridge, CB10 1SA, United Kingdom.
Steve D M BrownMammalian Genetics Unit, MRC Harwell Institute, Harwell Science and Innovation Campus, Oxfordshire, OX11 0RD, United Kingdom.
Sandra MercierCHU Nantes, Service de Génétique Médicale, 44093, Nantes, France.
Sylvie OdentFaculté de Médecine, Institut de Génétique et Développement de Rennes, UMR 6290, Université de Rennes 1, Rennes, France.
Jérôme CollignonInstitut Jacques Monod, UMR 7592, CNRS, Université Paris-Diderot, Sorbonne Paris Cité, 75013, Paris, France.ORCID 0000-0002-1212-4006
Shoumo BhattacharyaDepartment of Cardiovascular Medicine, BHF Centre of Research Excellence, University of Oxford, Roosevelt Drive, Headington, Oxford, OX3 7BN, United Kingdom. sbhattac@well.ox.ac.uk.ORCID 0000-0002-5571-0478
Centre for Human Genetics · GBCentre National de la Recherche Scientifique · FRInstitut de génétique et de développement de Rennes · FRWellcome Sanger Institute · GBCIC Rennes · FRGénétique Médicale & Génomique Fonctionelle · FRMary Lyon Centre at MRC Harwell · GB

Funding

ATHEROGENIC &ANTIATHEROGENIC LIPOPROTEINS IN CADF32HL008004 · NHLBI · OKLAHOMA MEDICAL RESEARCH FOUNDATION · PI WILSON, PAUL R · 1989 to 1990
–
HUMAN PULMONARY SURFACTANT PROTEINS IN MILKF32HL009003 · NHLBI · BAYLOR COLLEGE OF MEDICINE · PI YARUS, SINAI · 1994 to 1996
–
PERTUSSIS ADENYLATE CYCLASE: EFFECTS ON BLOOD CELLSK08HL001150 · NHLBI · UNIVERSITY OF MINNESOTA TWIN CITIES · PI CONFER, DENNIS L · 1985 to 1987
–
British Heart Foundation CH/09/003/26631British Heart Foundation FS/11/50/29038British Heart Foundation RE/08/004British Heart Foundation RE/13/1/30181British Heart Foundation RG/10/17/28553British Heart Foundation RM/13/3/30159British Heart Foundation (BHF) CH/09/003/26631British Heart Foundation (BHF) FS/11/50/29038British Heart Foundation (BHF) RE/08/004British Heart Foundation (BHF) RE/13/1/30181British Heart Foundation (BHF) RG/10/17/28553British Heart Foundation (BHF) RM/13/3/30159Medical Research Council MC_U142684172Wellcome Trust 077012/Z/05/ZWellcome Trust 083228Wellcome Trust 090532/Z/09/Z
6 · The paper itself

Abstract

ZIC2 mutation is known to cause holoprosencephaly (HPE). A subset of ZIC2 HPE probands harbour cardiovascular and visceral anomalies suggestive of laterality defects. 3D-imaging of novel mouse Zic2 mutants uncovers, in addition to HPE, laterality defects in lungs, heart, vasculature and viscera. A strong bias towards right isomerism indicates a failure to establish left identity in the lateral plate mesoderm (LPM), a phenotype that cannot be explained simply by the defective ciliogenesis previously noted in Zic2 mutants. Gene expression analysis showed that the left-determining NODAL-dependent signalling cascade fails to be activated in the LPM, and that the expression of Nodal at the node, which normally triggers this event, is itself defective in these embryos. Analysis of ChiP-seq data, in vitro transcriptional assays and mutagenesis reveals a requirement for a low-affinity ZIC2 binding site for the activation of the Nodal enhancer HBE, which is normally active in node precursor cells. These data show that ZIC2 is required for correct Nodal expression at the node and suggest a model in which ZIC2 acts at different levels to establish LR asymmetry, promoting both the production of the signal that induces left side identity and the morphogenesis of the cilia that bias its distribution.

Indexed as

MorphogenesisAnimalsBody PatterningCiliaHoloprosencephalyMesodermMiceMutationNodal ProteinNuclear ProteinsPhenotypeSignal TransductionTranscription FactorsNodal ProteinNodal protein, mouseNuclear ProteinsTranscription FactorsZIC2 protein, human

Identifiers

PMID29992973
PMCPMC6041270
OpenAlexW2881953587

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.